Ultra-fast LC-MS/MS in therapeutic drug monitoring: Quantification of clozapine and norclozapine in human plasma

Drug Test Anal. 2018 Feb;10(2):323-329. doi: 10.1002/dta.2223. Epub 2017 Jul 19.

Abstract

A novel approach to high-throughput, targeted liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis has been developed. A single chromatographic system can be used for the analysis of a range of 20 drugs and metabolites with a total analysis time of 36 s (one 96-well plate of prepared samples per hour). To demonstrate the applicability of this approach to quantitative analysis, a method has been validated for the therapeutic drug monitoring of clozapine and norclozapine following automated extraction from human plasma. Chromatographic retention times were 11.4 and 12.4 s for norclozapine and clozapine, respectively (for both analytes the chromatographic peak width was less than 1 s). Comparison with a conventional LC-MS/MS method (5 min analysis time) showed excellent agreement. This new approach offers analysis times more akin to flow-injection analysis, but is likely to be more widely applicable because of chromatographic resolution from residual matrix components and isobaric interferences.

Keywords: LC-MS/MS; TDM; clozapine; high-throughput; liquid chromatography; mass spectrometry.

MeSH terms

  • Antipsychotic Agents / blood*
  • Antipsychotic Agents / therapeutic use*
  • Chromatography, Liquid / methods*
  • Clozapine / analogs & derivatives*
  • Clozapine / chemistry
  • Clozapine / therapeutic use*
  • Drug Monitoring / methods
  • Humans
  • Plasma / metabolism*
  • Reproducibility of Results

Substances

  • Antipsychotic Agents
  • norclozapine
  • Clozapine